The HeBA survey is now closed to new participants.
Participants who joined the study between September 2022 and February 2024 can continue their participation through currently ongoing follow-up surveys and visit. As part of these ongoing follow-ups, you may receive emails directly from the HeBA study team (heba-study-luxembourg [at] ageinghealthy.eu or invite [at] lamapoll.de).
For more information about the different stages of the study, please see the latest news.
Thank you for your valuable contribution to our research. We greatly appreciate the time and effort you have dedicated to this study.
The Luxembourg Healthy Ageing Study aims to characterise the risk factors for developing age-related neurodegenerative diseases, especially Parkinson’s disease.
Neurodegenerative diseases are progressive diseases of the brain, like Parkinson’s or Alzheimer’s disease, that occur with ageing. It is estimated that 8.5 million people worldwide are affected by Parkinson’s disease and 55 million by Alzheimer’s disease or another form of dementia. With the higher life expectancy, this number will increase significantly in the coming years.
We are looking for participants living in Luxembourg and the Greater Region between 50 and 80 years old. With YOUR participation in this online survey, you can actively contribute to the research aims of this international study, which are
- Early detection of people in Luxembourg and the Greater Region at risk for developing age-related neurodegenerative disease;
- Discovery of novel risk factors for developing an age-related neurodegenerative disease;
- Gaining insight into strategies for preventing the development of neurodegenerative diseases.
The Luxembourg Healthy Ageing Study is part of an international effort in which scientists from Luxembourg, Germany, Austria and Spain collaborate to shed light on the risk factors underlying neurodegenerative diseases in Europe.